NIH-funded research NIH-funded research

Developing new antifungal drugs in a specialized lab

Official title: BSL3 Drug Screening Core

Funded at University of Texas San Antonio · NIH-11004651 · Data updated 2026-11-12

This study is working on a special lab to quickly test many new medicines to find out which ones can help fight harmful fungi that cause infections, with the hope that patients will have better treatment options in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas San Antonio
NIH-funded
Lab location1 site (San Antonio, United States)
Project startJanuary 1, 2022
Project endDecember 31, 2026
Funding year2025
Award (this year)$271,400
NIH project number5U19AI166761-04
Project IDNIH-11004651 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by Coccidioides spp. or other severe fungal infections.

Less likely to help

Patients with non-fungal infections or those who do not have a history of severe fungal infections may not benefit from this research.

What this research studies

This research focuses on creating a high-throughput screening (HTS) facility that operates under strict biosafety level 3 (BSL-3) conditions to test thousands of compounds for their effectiveness against harmful fungi, specifically Coccidioides spp. The goal is to establish methods for quickly and efficiently identifying new antifungal agents that can combat these pathogens. By using advanced techniques like imaging flow cytometry, the research aims to understand how these new drugs work and their potential effectiveness. Patients may benefit from new treatment options that arise from this innovative drug discovery process.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antifungal medications that are more effective against serious fungal infections.

How similar studies have gone: Other research has successfully utilized high-throughput screening in similar contexts, indicating a promising approach for drug discovery in this area.

Where this research is happening

  • University of Texas San Antonio
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Lopez-Ribot, Jose L. — University of Texas San Antonio
  • Study coordinator: Lopez-Ribot, Jose L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.